We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
- Authors
Molgaard-Hansen, Lene; Möttönen, Merja; Glosli, Heidi; Jónmundsson, Guðmundur K.; Abrahamsson, Jonas; Hasle, Henrik
- Abstract
Despite major improvements in the cure rate of childhood acute myeloid leukaemia (AML), 5-15% of patients still die from treatment-related complications. In a historical prospective cohort study, we analysed the frequency, clinical features and risk factors for early deaths (ED) and treatment-related deaths (TRD) in 525 children included in the Nordic Society of Paediatric Haematology and Oncology (NOPHO)-AML-84, -88 and -93 trials. Seventy patients (13%) died before starting treatment or from treatment-related complications. The death rate rose from 11% in NOPHO-AML-84 to 29% in -88, but then fell to 8% in -93. Sixteen patients (3%) died within the first 2 weeks, mainly from bleeding or leucostasis. Hyperleucocytosis, age <2 or ≥10 years were risk factors. After day 15, 10% of patients died from treatment-related complications with infection as the main cause of death. Risk factors were age <2 or ≥10 years and treatment according to the NOPHO-AML-88 protocol. The number of EDs and TRDs in AML is high. Therefore optimal antifungal prophylaxis is essential, and studies on the benefit of antibacterial prophylaxis and individual risk factors for ED and TRD are needed.
- Subjects
SCANDINAVIA; CHILD mortality; CAUSES of death; MYELOID leukemia; LEUKEMIA in children; THERAPEUTIC complications; COHORT analysis; PATIENTS
- Publication
British Journal of Haematology, 2010, Vol 151, Issue 5, p447
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/j.1365-2141.2010.08389.x